GEORGIA BIO HOSTS 2020 LIFE SCIENCES DAY AT THE STATE CAPITOL

Georgia Bio celebrated the life sciences industry at the Georgia State Capitol February 25, 2020. Georgia Bio’s annual Capitol Day is the chance for members to showcase their innovative products, services, and discoveries at the Georgia State Capitol in Atlanta. The event gives members the chance to meet one-on-one with Georgia’s policymakers. The overall mission of the event is to present to the Georgia General Assembly Georgia Bio’s legislative agenda and vision for life sciences economic growth.

During the day at the Georgia State Capitol, Georgia Bio had over thirty members in attendance focused on discussing with legislatures workforce & talent initiatives, patient access to care, and the creation of a Georgia Rare Disease Advisory Council. Below are a breakdown of the issues and what Georgia Bio supports.

To commend Georgia Bio and recognize February 25, 2020 as the Georgia Life Sciences day at the State Capitol, Governor Brian Kemp declared a Proclamation , Representative Robert Dickey (R – Musella) sponsored House Resolution 1056 and Senator John Wilkinson (R-Toccoa) sponsored Senate Resolution 674. Georgia Bio received special recognition on the Georgia House of Representatives chamber floor and Georgia Senate gallery.

Left to right (Rep. Terry England, Rep. Randy Nix, Phil Gibson, Rep. Robert Dickey, Kristin Boscan, Maria Thacker-Goethe, Speaker of the House Rep. David Ralston)

Presenters at our breakfast reception included:

  • Senator John Wilkinson (R – Toccoa), Chairman Agriculture and Consumer Affairs Committee
  • Senator Dean Burke (R – Bainbridge), Vice-Chairman Health & Human Services Committee
  • Senator Larry Walker (R – Perry), Member Health & Human Services Committee
  • Representative Robert Dickey (R – Musella), Chairman Appropriations Education Subcommittee
  • Representative Butch Parrish (R – Swainsboro), Chairman Appropriations Health Subcommittee
  • Maria Thacker-Goethe, President & CEO, Georgia Bio
  • Kallarin Mackey, Georgia Bio Policy & Advocacy Committee Chair & Director of State Affairs for Emory University
  • Phil Gibson, Ph.D., Georgia BioEd Chairman & Director, Georgia Bioscience Training Center, Quick Start
  • Andy Freeman, Georgia Government Relations Director, American Cancer Society

Georgia Bio gives a special thank you to Governor Brian Kemp, Rep. Robert Dickey & Senator John Wilkinson for sponsoring resolutions, and all the guest speakers and members for joining us in celebrating and showcasing their support to advance the life sciences industry in Georgia! Thank you to our event sponsors, Biotechnology Innovation Organization (BIO), AdvaMed, and UCB.

Workforce & Talent Initiatives:
The life science industry continues to fuel breakthrough discoveries that are having profound impacts around the globe. The life science sector in Georgia grew by 14.9% over the last decade. This high-paying and innovative sector is rapidly changing and the demand for new technical skills is on the rise, especially in Georgia. The industry routinely reports shortages of employees with the necessary skills.

Many life science careers utilize biological systems to produce commercially important biomaterials and biomolecules for use in agriculture, medicines, food and beverage processing, and industrial applications. Rural Georgia educators need support in life science career recognition, applicable hands-on teaching techniques, and access to supplies and equipment for their students.

Georgia Bio supports the state of Georgia to continue funding the Department of Education to advance Georgia BioEd’s Rural Teacher Training Initiative to strengthen Georgia’s life sciences workforce pipeline through classroom-to-career initiatives that align with industry needs.

Patient Access to Care:
Too many Georgians face barriers to accessing meaningful and timely care. In rural communities, many hospitals are struggling to keep their doors open. And throughout the state, even Georgians with coverage can face difficulties accessing specialty care or prescription drugs.

Georgia Bio supports patient access to innovative therapies and adequate provider networks through private and public insurance, including Medicaid, while enhancing plan transparency and encouraging competition among providers and insurers.

Establish a Georgia Rare Disease Advisory Council:

With over 7,000 known rare diseases, it is incredibly difficult for anyone to have an in-depth understanding of the entire rare community. Consequently, this lack of awareness contributes to some common difficulties that rare disease patients must face every day, such as delays in diagnosis, misdiagnosis, lack of treatment options, high drug costs, and limited access to medical specialists.

Rare Disease Advisory Councils help represent the needs of the entire rare disease community by giving patients, families, caregivers, and other stakeholders an opportunity to make formal recommendations to state leaders about the most important issue they face. Further, the membership of rare councils includes a variety of stakeholders that represent the entire rare community, including patients, caregivers, doctors, insurers, drug manufacturers, and researchers.

Georgia Bio supports the creation of a Georgia Rare Disease Advisory Council to address the needs of the rare disease community.

About Georgia Bio

Georgia Bio (GaBio), founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry.  It is the state’s largest and most influential life sciences advocacy and business leadership organization which works to improve access to innovative technologies and grow Georgia’s life sciences economy. Members include companies, universities, research institutions, government groups and other industry associations involved in discovery and application of life sciences products and related services that improve the health and well-being of people throughout the world.

Georgia Bio’s mission is to advance the growth of Georgia’s life sciences industry and foster strategic partnerships that can create a healthier world. To accomplish this mission, GaBio conducts business and economic development activities; advocates on behalf of the industry on public policy matters; educates the public about the benefits of life sciences research and product development; and provides a network for the exchange of ideas, information and opportunities.

###

January 20, 2026
January 20, 2026. Paulding County has been designated a BioReady Silver Community by Georgia Life Sciences, the state’s leading life sciences membership organization. The BioReady designation recognizes communities that demonstrate strong zoning practices, infrastructure capacity, and readiness to support biotechnology and life sciences development. “We are proud to recognize Paulding County as our newest BioReady Silver community,” said Maria Thacker-Goethe, President and CEO of Georgia Life Sciences. “Paulding County’s proactive planning, growing workforce, and access to regional healthcare and transportation infrastructure position it well to support life sciences manufacturing and commercialization. Through the BioReady program, we champion communities that are intentionally preparing to compete for industry investment and job growth.” Paulding County’s designation reflects its commitment to thoughtful land-use planning, scalable infrastructure, and business-friendly development policies that support life sciences and advanced manufacturing uses. Located in the northwest Atlanta metro region, the county offers access to a strong labor pool, major transportation corridors, and regional healthcare systems, making it an attractive option for biotechnology, medical device, diagnostics, and related life sciences companies seeking room to grow. “Georgia BioReady designation validates Paulding County’s readiness to support bioscience investment and strengthens our position as a growing hub for advanced industries,” said Alex Almodovar, President & CEO, Paulding County Economic Development Inc. & Industrial Building Authority The BioReady rating system evaluates communities across three tiers—Bronze, Silver, and Gold—based on their readiness to attract and support life sciences facilities. Through these ratings, Georgia Life Sciences helps municipalities better showcase biotech-appropriate sites, strengthen infrastructure planning, and clearly identify life sciences-friendly locations. This approach enables communities like Paulding County to compete more effectively for private investment and high-quality job creation. Georgia Life Sciences advances innovation, strengthens the workforce pipeline, and grows Georgia’s life sciences economy through the BioReady Community program, modeled after MassBio’s nationally recognized rating system, which assesses a community’s readiness to host life sciences facilities based on zoning practices and infrastructure capacity. About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
January 14, 2026
What happens when students see real work before choosing a future 
January 8, 2026
By: Patrick Plues | RealClearHealth January 8, 2026 For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments. But other countries, including China, are sparing no expense in the bid to overtake us. Beijing has officially made biotechnology a national strategic priority and is pouring billions into state-backed research and manufacturing efforts. All states should consider impactful biotech policies that grow and strengthen our domestic biotechnology industry. If states fail to utilize and replicate what are considered to be the best and most successful policies in biotech-focused economic development, the United States will soon lose its long-term leadership in developing medicines and medical technologies, which underpin our health, our economy, and our national security. Thankfully, many governors and state legislatures around the country are already answering this call -- as our new study, The U.S. Bioscience Industry: A Powerful Engine for State Economies, demonstrates. Keep Reading at https://www.realclearhealth.com/2026/01/08/americas_biotech_leadership_depends_on_the_states_1157584.html
MORE POSTS